Cargando…
A patient‐derived xenograft and a cell line derived from it form a useful preclinical model for small bowel adenocarcinoma
Basic and clinical studies on small bowel adenocarcinoma (SBA) are limited due to the rare nature of this cancer. We established a patient‐derived xenograft (PDX) model from the tumor tissue of an advanced SBA patient with liver and peritoneal metastasis, and a cell line from the PDX. In the PDX mod...
Autores principales: | Yamano, Tomoki, Kubo, Shuji, Tomita, Naohiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221307/ https://www.ncbi.nlm.nih.gov/pubmed/32168428 http://dx.doi.org/10.1002/cam4.2986 |
Ejemplares similares
-
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation
por: Serra-Camprubí, Queralt, et al.
Publicado: (2023) -
Splicing modulator FR901464 is a potential agent for colorectal cancer in combination therapy
por: Yamano, Tomoki, et al.
Publicado: (2019) -
Patient-derived xenografts as preclinical neuroblastoma models
por: Braekeveldt, Noémie, et al.
Publicado: (2017) -
Whole cell vaccination using immunogenic cell death by an oncolytic adenovirus is effective against a colorectal cancer model
por: Yamano, Tomoki, et al.
Publicado: (2016) -
Setting up a wide panel of patient-derived tumor xenografts of non–small cell lung cancer by improving the preanalytical steps
por: Ilie, Marius, et al.
Publicado: (2015)